<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02705326</url>
  </required_header>
  <id_info>
    <org_study_id>VUL_2R44DC013467_OptiSpeech</org_study_id>
    <secondary_id>2R44DC013467</secondary_id>
    <nct_id>NCT02705326</nct_id>
  </id_info>
  <brief_title>Evaluating the Efficacy of Opti-Speech for Speech Treatment</brief_title>
  <official_title>Evaluating the Efficacy of Opti-Speech, a 3D Visual Feedback System, for Speech Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vulintus, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Deafness and Other Communication Disorders (NIDCD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Callier Center for Communication Disorders</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cleveland Hearing and Speech Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Case Western Reserve University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vulintus, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if feedback from a three-dimensional real-time
      visualization of the tongue, a program called Opti-Speech, can be used to improve speech.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be asked to complete the Goldman Fristoe Test of Articulation along with
      several other assessment tests. Then speech treatment, guided by Opti-Speech, will be
      provided to the participant for up to 10 treatment sessions. The participant will be asked to
      come back after the final treatment for a 2-month follow-up assessment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent articulatory accuracy</measure>
    <time_frame>within 30 minutes of treatment</time_frame>
    <description>Sound probe lists will be administered within 30 minutes of treatment. Probe lists will be scored as correct or incorrect. The percentage of probes correct will be calculated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Accuracy of Speech Sound Production from Pre-Treatment to Post-Treatment</measure>
    <time_frame>Immediately prior to first speech treatment and 2 months after final treatment.</time_frame>
    <description>The Goldman Fristoe Test of Articulation will be administered prior to any speech treatment with Opti-Speech and again 2 months after the final speech treatment session. The percentage of consonants correct (PCC) will be used to assess the change in accuracy of speech sound production from pre-treatment to post-treatment</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Articulation Disorder</condition>
  <condition>Dysarthria</condition>
  <condition>Prelingual Deafness</condition>
  <arm_group>
    <arm_group_label>Opti-Speech</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Speech treatment will be guided by Opti-Speech's visual feedback of tongue movement during speech</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Opti-Speech</intervention_name>
    <description>Uses visual feedback of the tongue's motion to guide speech sound production</description>
    <arm_group_label>Opti-Speech</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English speaking individuals with speech errors resulting from persistent speech sound
             disorder, individuals with dysarthria resulting from neurological disorders and
             individuals with pre-lingual or congenital deafness.

        Exclusion Criteria:

          -  Cognitive impairments that affect their ability to understand and follow instructions
             by the treating speech language pathologists
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennell Vick, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveland Hearing and Speech Center, Case Western Reserve University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas F Campbell, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Callier Center for Communication Disorders at UT Dallas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Holle L Carey, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vulintus, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Holle L Carey</last_name>
    <phone>844-668-6872</phone>
    <phone_ext>703</phone_ext>
    <email>holle@vulintus.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas F Campbell, PhD</last_name>
    <phone>214-905-3001</phone>
    <email>thomas.f.campbell@utdallas.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Cleveland Hearing and Speech Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennell Vick, PhD</last_name>
      <phone>216-368-3352</phone>
      <email>jvick@chsc.org</email>
    </contact>
    <contact_backup>
      <last_name>Rebecca Mental</last_name>
      <email>rlm142@case.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Callier Center for Communication Disorders at UT Dallas</name>
      <address>
        <city>Richardson</city>
        <state>Texas</state>
        <zip>75080</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas F Campbell, PhD</last_name>
      <phone>214-905-3001</phone>
      <email>thomas.f.campbell@utdallas.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.vulintus.com/optispeech/</url>
    <description>Opti-Speech Demo</description>
  </link>
  <results_reference>
    <citation>Katz WF, Mehta S. Visual Feedback of Tongue Movement for Novel Speech Sound Learning. Front Hum Neurosci. 2015 Nov 19;9:612. doi: 10.3389/fnhum.2015.00612. eCollection 2015.</citation>
    <PMID>26635571</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2016</study_first_submitted>
  <study_first_submitted_qc>March 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2016</study_first_posted>
  <last_update_submitted>May 4, 2018</last_update_submitted>
  <last_update_submitted_qc>May 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Dysarthria</mesh_term>
    <mesh_term>Articulation Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

